Brief: Njaal Kind Appointed As Acting CEO In Gentian
April 29 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* NEW ACTING CEO AND CHAIRPERSON OF THE BOARD OF DIRECTORS
* APPOINTED ACTING CEO OF GENTIAN DIAGNOSTICS
* HILJA IBERT RESIGNS AS CEO, ELECTED BOARD CHAIRPERSON
* KIND WILL ALSO CONTINUE TO SERVE AS CFO AND COO
* NJAAL KIND APPOINTED AS ACTING CEO
Source text for Eikon: ID:nObi86hrra
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Gentian Diagnostics Q3 Sales At NOK 51.1 Million
Brief: Gentian Diagnostics Q2 EBITDA At NOK 8.1 Mln
Brief: Gentian Diagnostics Q2 EBITDA Up At NOK 8.1 Million
Brief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership